| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,134 | 0,176 | 09:59 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| 08.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 1 | HKEx | ||
| 06.07. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| 30.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 2 | HKEx | ||
| 26.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | 1 | HKEx | ||
| SIPAI HEALTH TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 23.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 18.06. | SIPAI HEALTH (00314): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, JUNE 18, 2026 | 2 | HKEx | ||
| 17.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | 1 | HKEx | ||
| 10.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | - | HKEx | ||
| 03.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 1 | HKEx | ||
| 01.06. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | 2 | HKEx | ||
| 27.05. | SIPAI HEALTH (00314): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 18, 2026 | - | HKEx | ||
| 27.05. | SIPAI HEALTH (00314): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 27.05. | SIPAI HEALTH (00314): PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; RE-ELECTION OF RETIRING DIRECTORS; RE-APPOINTMENT OF AUDITOR; ... | 1 | HKEx | ||
| 26.05. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 1 | HKEx | ||
| 18.05. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 1 | HKEx | ||
| 14.05. | SIPAI HEALTH (00314): FURTHER ANNOUNCEMENT ON DISCLOSEABLE TRANSACTION DISPOSAL OF 100% EQUITY INTEREST IN THE TARGET COMPANY | - | HKEx | ||
| 11.05. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | 2 | HKEx | ||
| 04.05. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - CHANGES IN ISSUED SHARES AND SHARE BUYBACKS | - | HKEx | ||
| 28.04. | SIPAI HEALTH (00314): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACKS | 3 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 69,68 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| BILLIONTOONE | 124,59 | -0,22 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,210 | +0,05 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BETA BIONICS | 16,860 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 62,37 | -0,10 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 25,500 | +0,04 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| ADAPTHEALTH | 10,190 | 0,00 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems | ||
| PROCEPT BIOROBOTICS | 19,300 | -0,05 % | PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 | ||
| PROGYNY | 32,360 | 0,00 % | KeyBanc raises Progyny stock price target on utilization strength | ||
| LIFESTANCE HEALTH GROUP | 10,795 | +0,05 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 28,030 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,350 | +0,11 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 6,290 | +0,16 % | BTIG hebt Kursziel für Oncology Institute Aktie nach Umschuldung auf 9 US-Dollar an | ||
| CLEARPOINT NEURO | 15,960 | 0,00 % | EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery | ||
| SIEMENS HEALTHINEERS | 34,030 | -0,76 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Siemens Healthineers von 55,80 auf 54,30 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. David Adlington passte seine... ► Artikel lesen |